AstraZeneca drops plans for Covid jab approval in US

Drugs giant AstraZeneca has abandoned plans to seek approval for its Covid-19 vaccine in the US as it revealed falling sales of the jab worldwide (Kirsty O’Connor/PA)

Drugs giant AstraZeneca has abandoned plans to seek approval for its Covid-19 jab in the US as it revealed falling sales of the vaccine worldwide.

The Anglo-Swedish group, which developed the Vaxzevria vaccine with Oxford University, revealed in its third-quarter results that it would drop an application with the Food and Drug Administration (FDA) in the US and instead focus its efforts elsewhere globally, including for its use as a booster.